Related Experiment Video
Updated: Aug 13, 2025

10:31
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
255
Single-cell transcriptomics: A new tool for studying diabetic kidney disease.
Zi-Hui Mao1,2,3,4, Zhong-Xiuzi Gao1,2,3,4, Yong Liu1,2,3,4
1Traditional Chinese Medicine Integrated Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Frontiers in Physiology
|January 23, 2023
Summary
Single-cell transcriptomics offers new insights into diabetic kidney disease (DKD) mechanisms. This review highlights key pathways and cell types, advancing understanding for better DKD treatment strategies.
Area of Science:
- Nephrology
- Genomics
- Molecular Biology
Background:
- Diabetic kidney disease (DKD) is a major cause of kidney failure and cardiovascular issues.
- The intricate structure of the kidney and DKD's complexity hinder full understanding of its development.
- Single-cell sequencing technologies provide high-resolution analysis of cellular heterogeneity.
Purpose of the Study:
- To review the application of single-cell transcriptomics in studying DKD.
- To identify key signaling pathways and cell types involved in DKD pathogenesis.
- To explore how single-cell transcriptomics can inform future DKD treatment strategies.
Main Methods:
- Review of existing literature on single-cell transcriptomics in DKD research.
- Focus on single-cell RNA sequencing (scRNA-seq) and single-nucleus RNA sequencing (snRNA-seq) applications.
- Analysis of gene expression patterns and signaling pathways in specific kidney cell types.
Main Results:
- Single-cell transcriptomics reveals cell-type-specific alterations in DKD.
- Identified key signaling pathways crucial for DKD initiation and progression.
- Highlighted the heterogeneity of cellular responses within the kidney during DKD.
Conclusions:
- Single-cell transcriptomics is a powerful tool for dissecting DKD complexity.
- Understanding cellular mechanisms through scRNA-seq provides novel therapeutic targets.
- This approach offers a pathway to improved diagnostic and treatment strategies for DKD.

